MORESCO, ROSA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 14.733
EU - Europa 6.622
AS - Asia 2.495
SA - Sud America 19
AF - Africa 14
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 8
Totale 23.905
Nazione #
US - Stati Uniti d'America 14.474
IT - Italia 1.346
DE - Germania 1.305
SE - Svezia 1.076
CN - Cina 923
SG - Singapore 814
IE - Irlanda 763
RU - Federazione Russa 548
UA - Ucraina 519
GB - Regno Unito 367
HK - Hong Kong 299
CA - Canada 251
VN - Vietnam 183
FI - Finlandia 178
AT - Austria 127
FR - Francia 110
IN - India 98
DK - Danimarca 76
TR - Turchia 58
NL - Olanda 49
BE - Belgio 40
PL - Polonia 40
ID - Indonesia 32
CH - Svizzera 22
IR - Iran 19
KR - Corea 18
JP - Giappone 16
BR - Brasile 13
AU - Australia 11
CZ - Repubblica Ceca 10
ES - Italia 10
TW - Taiwan 10
RO - Romania 8
MX - Messico 6
BG - Bulgaria 5
EU - Europa 5
CL - Cile 4
DZ - Algeria 4
EG - Egitto 4
MY - Malesia 4
PT - Portogallo 4
TH - Thailandia 4
HU - Ungheria 3
IL - Israele 3
LT - Lituania 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
LI - Liechtenstein 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
PK - Pakistan 2
TM - Turkmenistan 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
EC - Ecuador 1
GR - Grecia 1
KZ - Kazakistan 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
SC - Seychelles 1
SZ - Regno dello Swaziland 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 23.905
Città #
Ann Arbor 3.335
Fairfield 1.401
Woodbridge 1.297
Houston 1.021
Chandler 862
Wilmington 750
Dublin 734
Ashburn 733
Frankfurt am Main 707
Singapore 700
Jacksonville 581
Seattle 512
Dearborn 475
Cambridge 401
Milan 375
New York 372
Santa Clara 348
Princeton 296
Hong Kong 291
Nanjing 202
Lawrence 141
Altamura 132
Vienna 117
Shanghai 116
Beijing 97
Lachine 96
San Diego 93
Toronto 92
Dong Ket 91
Helsinki 61
Boardman 56
Shenyang 54
Nanchang 47
Fremont 46
Rome 46
Andover 41
London 40
Tianjin 40
Brussels 39
Guangzhou 37
Jinan 37
Nürnberg 36
Kraków 35
Falls Church 34
Hebei 34
Changsha 30
Chicago 30
Jakarta 30
Jiaxing 29
Hangzhou 26
Huizen 26
Mountain View 26
Munich 26
Ottawa 26
Monza 25
Auburn Hills 19
Bonndorf 19
Kunming 19
Los Angeles 18
Montréal 18
Zhengzhou 18
Norwalk 17
Pune 15
Washington 15
Ningbo 14
Philadelphia 14
Edmonton 13
Verdellino 13
Naples 12
Padova 12
Turin 12
Redmond 11
Hefei 10
Taizhou 10
University Park 10
Bologna 9
Lanzhou 9
Spoltore 9
Ahmedabad 8
Brescia 8
Busto Arsizio 8
Dallas 8
Haikou 8
Linz 8
Melzo 8
Napoli 8
Rho 8
Torino 8
Brno 7
Carate Brianza 7
Genoa 7
Harbin 7
Pisa 7
Sacramento 7
Wuhan 7
Amsterdam 6
Catania 6
Como 6
Lappeenranta 6
Melbourne 6
Totale 17.800
Nome #
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study 375
99mTc-radiolabeled silica nanocarriers for targeted detection and treatment of HER2-positive breast cancer 358
Development of99mtc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer 356
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 348
Study of the Tissue Distribution of TLQP-21 in Mice Using [18F]JMV5763, a Radiolabeled Analog Prepared via [18F]Aluminum Fluoride Chelation Chemistry 347
Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors 334
Acute Inescapable Stress Rapidly Increases Synaptic Energy Metabolism in Prefrontal Cortex and Alters Working Memory Performance 311
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 306
Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration 300
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 290
Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models 284
Radiosynthesis and Preclinical Evaluation of 11C-VA426, a Cyclooxygenase-2 Selective Ligand 276
Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling 259
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 256
From cancer metabolism to new biomarkers and drug targets 254
18 F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis 238
Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation 231
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 231
Role of metformin and AKT axis modulation in the reversion of hypoxia induced TMZ-resistance in glioma cells 220
A systems biology road map for the discovery of drugs targeting cancer cell metabolism 214
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 214
Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model 213
Stem Cell-Derived Human Striatal Progenitors Innervate Striatal Targets and Alleviate Sensorimotor Deficit in a Rat Model of Huntington Disease 205
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling 203
Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis 203
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG 202
Validation of an Engineered Cell Model for In Vitro and In Vivo HIF-1α Evaluation by Different Imaging Modalities 197
Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury 196
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 195
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 193
Metabolic evaluation of non-small cell lung cancer patient-derived xenograft models using 18F-FDG PET: A potential tool for early therapy response 191
Basal ganglia and language: Phonology modulates dopaminergic release 188
Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195 187
Ibuprofen plus isosorbide dinitrate treatment in the mdx mice ameliorates dystrophic heart structure 186
Sperimentazione clinica con radiofarmaci 182
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts 180
Imaging temozolomide-induced changes in the myeloid glioma microenvironment 180
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 178
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 175
A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset 175
Evaluation of the Role of Tumor-Associated Macrophages in an Experimental Model of Peritoneal Carcinomatosis Using 18F-FDG PET 175
The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis 175
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 173
A Decision Support System for the assisted diagnosis of brain tumors: a feasibility study for ¹⁸F-FDG PET preclinical studies 172
Characterization of preclinical models of prostate cancer using PET-based molecular imaging 169
Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients: Role of free fatty acid and insulin levels 169
SPM for activation studies in rats on stress condition 167
Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice 167
Acute stress studies in rats by 18 FDG PET and SPM 167
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 166
Omegaconotoxin binding decreases in aged rat brain 166
The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]fluorodeoxyglucose: theory, implementation, and optimization procedures 165
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 165
Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method 164
Regional Differences in Cerebral Glucose Metabolism After Cardiac Arrest and Resuscitation in Rats Using [18F]FDG Positron Emission Tomography and Autoradiography 164
[11C]-MP4A PET Cholinergic Measurements in Amnestic Mild Cognitive Impairment, Probable Alzheimer's Disease, and Dementia with Lewy Bodies: A Bayesian Method and Voxel-Based Analysis 163
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 162
Increased 5-Hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: A positron emission tomography scan study 161
Preparation of [76Br]FLB 457 and [76Br]FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET 161
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 161
Voltage-operated calcium-channel subtypes in human neuroblastoma and rat pheochromocytoma cells 161
Quantification of Dynamic [18F]FDG Pet Studies in Acute Lung Injury 161
Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a PET study 160
Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells 159
Acute effect of 3-(4-acetamido)-butyrril-lorazepam (dds2700) on brain function assessed by pet at rest and during attentive tasks 158
Cholinergic activity correlates with reserve proxies in Alzheimer's disease 157
Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mouse 156
[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer 155
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 153
Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [18F]fluoro-ethyl-spiperone 152
Tumour hypoxia: lessons learnt from preclinical imaging 152
An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease 151
Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum 151
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 151
Lead neurotoxicity: A role for dopamine receptors 149
Is delirium the cognitive harbinger of frailty in older adults? A review about the existing evidence 149
GABAa receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil 148
In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder 148
In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study 148
Effects of dopamine on the in vivo binding of dopamine D2 receptor radioligands in rat striatum 146
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 145
Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer 145
[18f]-(2S,4R)-4-Fluoroglutamine As a New Positron Emission Tomography Tracer in Multiple Myeloma 144
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 143
Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease 143
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 141
Cerebral D2 and 5HT5 receptor occupancy in schizophrenic patients treated with olanzapine or clozapine 141
3D Spatial resolution proprieties of Molecubes β-Cube: Characterization with different isotopes 141
PET and SPET molecular imaging: Focus on serotonin system 140
Radiosynthesis and preliminary biological evaluation of [18F]VC701, a radioligand for translocator protein 140
Validation and Performance Assessment of a Preclinical SiPM-Based SPECT/MRI Insert 139
Adenosine A2A receptors and basal ganglia physiology 136
Differentiation of human telencephalic progenitor cells into MSNs by inducible expression of Gsx2 and Ebf1 136
Molecular imaging of individual behaviour 135
Effect of chronic calcium antagonist treatment on dopamine recognition sites in rat striatum. 133
PET evidence of central GABAergic changes in stiff person syndrome 132
Feasibility of supervised machine learning technique for assisted diagnosis of cancer: application to PET studies in small animals 132
PET in psychopharmacology 131
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 130
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 129
Totale 18.784
Categoria #
all - tutte 82.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.904 0 0 0 0 410 541 631 299 418 255 260 90
2020/20213.544 172 228 369 432 248 297 291 266 279 329 220 413
2021/20222.677 205 273 372 287 168 187 144 148 147 183 191 372
2022/20233.728 453 1.022 338 315 285 531 60 203 271 42 117 91
2023/20242.717 115 101 102 137 340 718 485 90 219 65 45 300
2024/20252.301 383 690 518 276 434 0 0 0 0 0 0 0
Totale 24.732